Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy

Fig. 7

CAM vasculature development on day 12 of egg development treated with liposomal formulations. (A) shows the stereomicroscope of the CAM vessels. (B) shows relative vascular density as compared to the control group. Data are expressed as mean ± standard deviation (n = 3). The statistical significant differences are designated as follows: *P < 0.05, **P < 0.01, ****P < 0.0001

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us